Peripartum cardiomyopathy

Archives of Gynecology and Obstetrics

Volumn 281, Issue 2, 2010, Pages 183-188

  Moioli, Melita ^a   Menada, Mario Valenzano ^a   Bentivoglio, Giorgio ^a   Ferrero, Simone ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Heart failure; Peripartum cardiomyopathy; Pregnancy

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ENALAPRIL; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; INTERLEUKIN 1; INTERLEUKIN 6; LISINOPRIL; LOOP DIURETIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; MILRINONE; NESIRITIDE; NITRATE; NITROPRUSSIDE SODIUM; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

ALKALOSIS; ANTITHROMBIN III DEFICIENCY; ARTERY THROMBOSIS; BLEEDING; CARBOHYDRATE TOLERANCE; CARDIOMEGALY; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; EARLY DIAGNOSIS; HEART AFTERLOAD; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEMODYNAMIC PARAMETERS; HEMODYNAMIC STRESS; HIGH RISK PREGNANCY; HUMAN; HYPERURICEMIA; HYPOKALEMIA; HYPONATREMIA; IMMUNE RESPONSE; LUNG DISEASE; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MYOCARDITIS; NONHUMAN; OSTEOPOROSIS; PANCREATITIS; PERIPARTUM CARDIOMYOPATHY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PROGNOSIS; RARE DISEASE; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; REVIEW; SIDE EFFECT; SODIUM RESTRICTION; SYSTOLIC DYSFUNCTION; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; VEIN THROMBOSIS; VIRUS INFECTION; CARDIOMYOPATHY; FEMALE; PATHOPHYSIOLOGY; PREGNANCY;

CARDIOMYOPATHIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 77950353417     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-009-1170-5     Document Type: Review

References (68)

1. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL (2000) Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and OYce of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283:1183-1188 (Pubitemid 30126607)
2. Richie C. (1849) Clinical contribution to the pathology, diagnosis and treatment of certain chronic diseases of the heart. Edinb Med Surg J 2:333-342
3. Gouley B, McMillan T, Bellet S. (1937) Idiopathic myocardical degeneration associated with pregnancy and especially the puerperium. Am J Med Sci 19:185-199
4. Hull E, Hidden E. (1938) Postpartal heart failure. South Med J 31:265-270
5. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, Gunnar RM (1971) Natural course of peripartum cardiomyopathy. Circulation 44:1053-1061
6. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A (2005) Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111:2050-2055 (Pubitemid 40577899)
7. Whitehead SJ, Berg CJ, Chang J (2003) Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997. Obstet Gynecol 102:1326-1331 (Pubitemid 37518414)
8. Fett JD, Christie LG, Carraway RD, Murphy JG (2005) Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 80:1602-1606
9. Desai D, Moodley J, Naidoo D (1995) Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop Doct 25:118-123
10. Mielniczuk LM, Williams K, Davis DR, Tang AS, Lemery R, Green MS, Gollob MH, Haddad H, Birnie DH (2006) Frequency of peripartum cardiomyopathy. Am J Cardiol 97:1765-1768 (Pubitemid 43817868)
11. Alvarez Navascues R, Marin R, Testa A, Paneda F, Alvarez Grande J (2001) Preeclampsia and peripartum cardiomyopathy: infrequent association. Nefrologia 21:84-87
12. Fett JD (2005) Peripartum cardiomyopathy (PPCM) in both surrogate and biological mother. Hum Reprod 20:2666-2668
13. Veille JC (1984) Peripartum cardiomyopathies: a review. Am J Obstet Gynecol 148:805-818
14. Demakis JG, Rahimtoola SH (1971) Peripartum cardiomyopathy. Circulation 44:964-968
15. Mendelson MA, Chandler J (1992) Postpartum cardiomyopathy associated with maternal cocaine abuse. Am J Cardiol 70:1092-1094
16. Pierce JA, Price BO, Joyce JW (1963) Familial occurrence of postpartal heart failure. Arch Intern Med 111:651-655
17. Pearl W (1995) Familial occurrence of peripartum cardiomyopathy. Am Heart J 129:421-422
18. Melvin KR, Richardson PJ, Olsen EG, Daly K, Jackson G. (1982) Peripartum cardiomyopathy due to myocarditis. N Engl J Med 307:731-734
19. Felker GM, Jaeger CJ, Klodas E, Thiemann DR, Hare JM, Hruban RH, Kasper EK, Baughman KL (2000) Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 140:785-791
20. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL (1990) Peripartum myocarditis and cardiomyopathy. Circulation 81:922-928
21. Cenac A, Gaultier Y, Devillechabrolle A, Moulias R (1988) Enterovirus infection in peripartum cardiomyopathy. Lancet 2:968-969
22. Bultmann BD, Klingel K, Nabauer M, Wallwiener D, Kandolf R (2005) High prevalence of viral genomes and inXammation in peripartum cardiomyopathy. Am J Obstet Gynecol 193:363-365 (Pubitemid 41159528)
23. Cenac A, Djibo A, Chaigneau C, Velmans N, OrWla J (2003) Are anti-Chlamydia pneumoniae antibodies prognosis indicators for peripartum cardiomyopathy? J Cardiovasc Risk 10:195-199 (Pubitemid 36735195)
24. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P (2000) Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO- 1. J Am Coll Cardiol 35:701-705 (Pubitemid 30167027)
25. Brown CS, Bertolet BD (1998) Peripartum cardiomyopathy: a comprehensive review. Am J Obstet Gynecol 178:409-414
26. Coulson CC, Thorp JM Jr, Mayer DC, Cefalo RC (1996) Central hemodynamic effects of recombinant human relaxin in the isolated, perfused rat heart model. Obstet Gynecol 87:610-612
27. Kothari SS (1997) Aetiopathogenesis of peripartum cardiomyopathy: prolactin-selenium interaction? Int J Cardiol 60:111-114
28. O'Connell JB, Costanzo-Nordin MR, Subramanian R, Robinson JA, Wallis DE, Scanlon PJ, Gunnar RM (1986) Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol 8:52-56 (Pubitemid 16094113)
29. Carvalho A, Brandao A, Martinez EE, Alexopoulos D, Lima VC, Andrade JL, Ambrose JA (1989) Prognosis in peripartum cardiomyopathy. Am J Cardiol 64:540-542 (Pubitemid 19214590)
30. HilWker-Kleiner D, Sliwa K, Drexler H (2008) Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovasc Med 18(5):173-179
31. HilWker-Kleiner D, Kaminski, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O et al (2007) A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128(3):589-600 (Pubitemid 46206082)
32. Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM (2007) Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol 118:295-303 (Pubitemid 46695762)
33. Ferrero S, Colombo BM, Fenini F, Abbamonte LH, Arena E. (2003) Peripartum cardiomyopathy. A review. Minerva Ginecol 55(139-151):151-158
34. Lee W (1991) Clinical management of gravid women with peripartum cardiomyopathy. Obstet Gynecol Clin North Am 18:257-271
35. Homans DC (1985) Peripartum cardiomyopathy. N Engl J Med 312:1432-1437 (Pubitemid 15083662)
36. Brandenburg RO, Chazov E, Cherian G, Falase AO, Grosgogeat Y, Kawai C, Loogen F, Martin Judez V, Goodwin JF, Olsen EGJ, Oakley CM, Pisa Z (1980) Report of the WHO/ISFC task force on the deWnition and classiWcation of cardiomyopathies. Br Heart J 44:672-673
37. Yacoub A, Martel MJ (2002) Pregnancy with primary dilated cardiomyopathy. Obstet Gynecol 99:928-930
38. Meadows WR (1957) Idiopathic myocardial failure in the last trimester of pregnancy and the puerperium. Circulation 15:903-914
39. Walsh JJ, Burch GE, Black WC, Ferrans VJ, Hibbs RG (1965) Idiopathic myocardiopathy of the puerperium (postpartal heart disease). Circulation 32:19-31
40. Sanderson JE, Adesanya CO, Anjorin FI, Parry EH (1979) Postpartum cardiac failure - heart failure due to volume overload? Am Heart J 97:613-621 (Pubitemid 10160944)
41. Mann MS, Cossham PS, Baker JL, Hurley PA (1987) Left atrial myxoma in the second trimester of pregnancy. Case report. Br J Obstet Gynaecol 94:592-593 (Pubitemid 17077772)
42. Hibbard JU, Lindheimer M, Lang RM (1999) A modiWed deWnition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 94:311-316 (Pubitemid 29352883)
43. Hauck AJ, Kearney DL, Edwards WD (1989) Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 64:1235-1245
44. Murali S, Baldisseri MR (2005) Peripartum cardiomyopathy. Crit Care Med 33:S340-S346 (Pubitemid 41437459)
45. Lindheimer MD, Katz AI (1973) Sodium and diuretics in pregnancy. N Engl J Med 288:891-894
46. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M et al (1991) A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325:303-310
47. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH et al (1996) Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 335:1107-1114 (Pubitemid 26330964)
48. Stempel JE, O'Grady JP, Morton MJ, Johnson KA (1982) Use of sodium nitroprusside in complications of gestational hypertension. Obstet Gynecol 60:533-538 (Pubitemid 12018890)
49. Mastrobattista JM (1997) Angiotensin converting enzyme inhibitors in pregnancy. Semin Perinatol 21:124-134 (Pubitemid 27264001)
50. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK (1993) Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol 22:955-962
51. Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, Smith LK, Van Voorhees L, Gourley LA, Jolly MK (1993) Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med 329:1-7 (Pubitemid 23182871)
52. White WB (1984) Management of hypertension during lactation. Hypertension 6:297-300
53. Anderson JL, Gilbert EM, O'Connell JB, Renlund D, Yanowitz F, Murray M, Roskelley M, Mealey P, Volkman K, Deitchman D et al (1991) Long-term (2 year) beneWcial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 17:1373-1381
54. Andersson B, Blomstrom-Lundqvist C, Hedner T, Waagstein F (1991) Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol 18:1059-1066
55. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334:1349-1355
56. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE (1995) A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333:269-275
57. Bozkurt B, Villaneuva FS, Holubkov R, Tokarczyk T, Alvarez RJ Jr, MacGowan GA, Murali S, Rosenblum WD, Feldman AM, McNamara DM (1999) Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 34:177-180
58. Box LC, Hanak V, Arciniegas JG (2004) Dual coronary emboli in peripartum cardiomyopathy. Tex Heart Inst J 31:442-444 (Pubitemid 39627886)
59. Nishi I, Ishimitsu T, Ishizu T, Ueno Y, Suzuki A, Seo Y, Ohtsuka S, Iida K, Yamaguchi I (2002) Peripartum cardiomyopathy and biventricular thrombi. Circ J 66:863-865 (Pubitemid 34988225)
60. Jha P, Jha S, Millane TA (2005) Peripartum cardiomyopathy complicated by pulmonary embolism and pulmonary hypertension. Eur J Obstet Gynecol Reprod Biol 123:121-123 (Pubitemid 41563108)
61. Bennani SL, Loubaris M, Lahlou I, Haddour N, Badidi M, Bouhouch R, Cherti M, Arharbi M (2003) Postpartum cardiomyopathy revealed by acute lower limb ischemia. Ann Cardiol Angeiol (Paris) 52:382-385 (Pubitemid 38017016)
62. Pettifor JM, Benson R (1975) Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr 86:459-462
63. Rasmusson KD, Stehlik J, Brown RN, Renlund DG, Wagoner LE, Torre-Amione G, Folsom JW, Silber DH, Kirklin JK (2007) Longterm outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multiinstitutional analysis. J Heart Lung Transplant 26:1097-1104 (Pubitemid 350088514)
64. HilWker-Kleiner D, Meyer GP, SchieVer E, Goldmann B, Podewsky E, Struman I et al (2007) Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J Am Coll Cardiol 50(24):2354-2355 (Pubitemid 350192108)
65. Jahns BG, Stein W, HilWker-Kleiner D, Pieske B, Emons G. (2008) Peripartum cardiomyopathy - a new treatment option by inhibition of prolactin secretion. Am J Obstet Gynecol 199(4):e5-e6
66. Sutton MS, Cole P, Plappert M, Saltzman D, Goldhaber S. (1991) Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J 121:1776-1778
67. Amos AM, Jaber WA, Russell SD (2006) Improved outcomes in peripartum cardiomyopathy with contemporary. Am Hearth J 152(3):509-513
68. Fett JD, Christie LG, Murphy JG (2006) Brief communication: outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Ann Intern Med 145:30-34 (Pubitemid 46780602)